Grifols (GIKLY) Current Taxes (2009 - 2025)
Grifols (GIKLY) posted Current Taxes of $29.1 million for Q4 2025, down 55.36% quarter-over-quarter from $65.2 million in Q4 2024, and down 55.36% year-on-year from $65.2 million in Q4 2024.
Grifols (GIKLY) Current Taxes (2009 - 2025) Analysis & Trends
Grifols (GIKLY) has reported Current Taxes for 16 consecutive years, with $29.1 million the latest figure, recorded in Q4 2025.
- Current Taxes for Q4 2025 came in at $29.1 million, down 55.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $29.1 million (down 55.36% YoY), and the FY2025 annual result was $29.1 million, down 55.36% from the prior year.
- Current Taxes was $29.1 million for Q4 2025 at Grifols, down from $65.2 million in the prior quarter.
- Over five years, Current Taxes peaked at $65.2 million in Q4 2024 and troughed at $5.2 million in Q4 2021.
- Average Current Taxes over 5 years is $26.2 million, with a median of $16.0 million recorded in 2022.
- Year-over-year, Current Taxes surged 317.16% in 2024 and slumped 55.36% in 2025.
- Over 5 years, Current Taxes stood at $5.2 million in 2021, then surged by 209.8% to $16.0 million in 2022, then declined by 2.37% to $15.6 million in 2023, then soared by 317.16% to $65.2 million in 2024, then plunged by 55.36% to $29.1 million in 2025.
- Per Business Quant data, the three most recent Current Taxes figures were $29.1 million in Q4 2025, $65.2 million in Q4 2024, and $15.6 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.09 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -1.30 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 3.95 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.13 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Grifols | - | - | - | 29.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.10 Mn |
| Dec 31, 2024 | 65.18 Mn |
| Dec 31, 2023 | 15.63 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Dec 31, 2021 | 5.17 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Dec 31, 2019 | 6.60 Mn |
| Dec 31, 2018 | 2.19 Mn |
| Jun 30, 2018 | 24.20 Mn |
| Dec 31, 2017 | 7.90 Mn |
| Jun 30, 2017 | 23.02 Mn |
| Dec 31, 2016 | 8.59 Mn |
| Sep 30, 2016 | 24.51 Mn |
| Jun 30, 2016 | 36.95 Mn |
| Dec 31, 2015 | 17.75 Mn |
| Sep 30, 2015 | 43.88 Mn |
| Jun 30, 2015 | 107,468.36 |
| Mar 31, 2015 | 113.58 Mn |
| Dec 31, 2014 | 109.31 Mn |
| Sep 30, 2014 | 78.87 Mn |